ENTRY       D11358                      Drug
NAME        Tagraxofusp (USAN/INN);
            Tagraxofusp-erzs;
            Elzonris (TN)
PRODUCT     ELZONRIS (Stemline Therapeutics)
FORMULA     C2553H4026N692O798S16
EXACT_MASS  57659.1258
MOL_WEIGHT  57694.4811
SEQUENCE    MGADDVVDSS KSFVMENFSS YHGTKPGYVD SIQKGIQKPK SGTQGNYDDD WKGFYSTDNK
            YDAAGYSVDN ENPLSGKAGG VVKVTYPGLT KVLALKVDNA ETIKKELGLS LTEPLMEQVG
            TEEFIKRFGD GASRVVLSLP FAEGSSSVEY INNWEQAKAL SVELEINFET RGKRGQDAMY
            EYMAQACAGN RVRRSVGSSL SCINLDWDVI RDKTKTKIES LKEHGPIKNK MSESPNKTVS
            EEKAKQYLEE FHQTALEHPE LSELKTVTGT NPVFAGANYA AWAVNVAQVI DSETADNLEK
            TTAALSILPG IGSVMGIADG AVHHNTEEIV AQSIALSSLM VAQAIPLVGE LVDIGFAAYN
            FVESIINLFQ VVHNSYNRPA YSPGHKTRPH MAPMTQTTSL KTSWVNCSNM IDEIITHLKQ
            PPLPLLDFNN LNGEDQDILM ENNLRRPNLE AFNRAVKSLQ NASAIESILK NLLPCLPLAT
            AAPTRHPIHI KDGDWNEFRR KLTFYLKTLE NAQAQQTTLS LAIF
            (Disulfide bridge: 187-202, 407-475)
  TYPE      Peptide
REMARK      ATC code: L01XX67
            Product: D11358<US>
EFFICACY    Antineoplastic, Immunotoxin
COMMENT     Fusion protein, diphteria toxin-interleukin 3
            Treatment of blastic plasmacytoid dendritic cell neoplasm (CD123-directed)
TARGET      IL3RA (CD123) [HSA:3563] [KO:K04737]
  PATHWAY   hsa04210(3563)  Apoptosis
            hsa04640(3563)  Hematopoietic cell lineage
            hsa05200(3563)  Pathways in cancer
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01X OTHER ANTINEOPLASTIC AGENTS
                L01XX Other antineoplastic agents
                 L01XX67 Tagraxofusp
                  D11358  Tagraxofusp (USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Molecular Target Inhibitors
               Tagraxofusp
                D11358  Tagraxofusp (USAN/INN)
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Interleukin receptors
                IL3RA (CD123)
                 D11358  Tagraxofusp (USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11358
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11358
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11358
DBLINKS     CAS: 2055491-00-2
            PubChem: 384585336
///
